Has Ariel Ostad received payments from drug or device companies?

Yes. Drug and device makers reported $35,582 in general payments to Ariel Ostad across 159 transactions between 2019–2025. Most Open Payments records nationally are meals worth under $20; a reported payment is not evidence of wrongdoing.

Does a payment mean Ariel Ostad did something wrong?

No. Federal law requires drug and device makers to report almost every transfer of value to a physician, including a $14 sandwich at a lunch presentation. Consulting fees, research funding and royalties to device inventors are ordinary, legal parts of medicine. This site reports what was disclosed; it makes no allegation.

Where does this information about Ariel Ostad come from?

The U.S. Centers for Medicare & Medicaid Services. Payments come from Open Payments, published under the Physician Payments Sunshine Act. Billing and prescribing figures come from the Medicare Physician & Other Practitioners and Part D Prescriber public use files for 2024.

Ariel Ostad

Procedural Dermatology · New York, NYNPI 1104817675

Payments from drug & device makers

What this record shows

The money is spread across several categories — consulting fees (57.3%), speaking fees and food and beverage — rather than concentrated in one kind of arrangement. Regeneron Healthcare Solutions, Inc. accounts for 60.6% of it on its own, with 12 other manufacturers making up the rest. Reporting peaked in 2022 at $32,134 and has fallen 97.7% since, to $735 in 2025.

$35,582in general payments, 2019–2025

Across 159 payments — averaging $223.79 each. Meals, travel, consulting and speaking fees, gifts and royalties reported by drug and device makers.

Regeneron Healthcare Solutions, Inc.$22K
AbbVie$13K
Galderma Laboratories, L.p.$129
Intuity Medical Inc$111
Pfizer$68
VYNE Pharmaceuticals Inc.$61
plus $229 from 7 others

What the payments were for

Consulting fees$20,40657%
Speaking & faculty fees$11,29332%
Travel & lodging$1,1073%
Food & beverage$2,7688%
Education$80%

General payments by program year

Who reported the general payments

Companies are grouped under their corporate parent — a single manufacturer often files under several CMS reporting entities. Research and ownership payments are counted separately and are not in this table.

Company	Payments	Total
Regeneron Healthcare Solutions, Inc.	14	$21,546
AbbVie(2 entities)	119	$13,439
Galderma Laboratories, L.p.	8	$129
Intuity Medical Inc	1	$111
Pfizer	3	$68
VYNE Pharmaceuticals Inc.	3	$61
Merz North America, Inc.	2	$52
Ortho Dermatologics, A Division Of Bausch Health US, LLC	2	$44
Dermira, Inc.	2	$44
Solta Medical, A Division Of Bausch Health US, LLC	2	$40
EPI Health, LLC	1	$17
Sun Pharmaceutical Industries Inc.	1	$16
Journey Medical Corporation	1	$16

What the payments were tied to

Products named in the reported payments. Only payments of $100 or more are attributed here — the typical reported payment nationally is a meal worth about $16, and listing those product-by-product would be noise.

LIBTAYO$21,385
Pogo Automatic Blood Glucose Monitoring System$111

How this compares

$35,582 in reported general payments places this provider in the 85th percentile of 69 procedural dermatology providers in New York.

See all procedural dermatology providers in New York →

Most prescribed under Part D

Drug	Claims	Cost to plans & patients
Clobetasol Propionate	22	$718
Minoxidil	52	$659
Doxycycline Hyclate	36	$590
Mupirocin	13	$154

Paid to pharmacies, not to this prescriber.

Other procedural dermatology in New York

Michelle HenryNew York$460K
Jerry ShapiroNew York$414K
Dendy EngelmanNew York$292K
Evan RiederNew York$210K
Daniel Belkin-HollandNew York$208K
Elizabeth HaleNew York$34K
Heidi WaldorfNew York$29K
Robert FinneyNew York$19K
Shera AranoffNew York$8K
Lisa RothmanNew York$7K

See the full list for New York →

Where these figures come from

Payments: CMS Open Payments, program years 2019–2025 (publication P06302026_06032026).
Identity: NPPES NPI Registry, July 2026.

Is this you, or does something look wrong? →